Literature DB >> 4580007

Patterns of nuclear fluorescence and DNA-binding activity.

A Luciano, N F Rothfield.   

Abstract

Mesh:

Substances:

Year:  1973        PMID: 4580007      PMCID: PMC1006112          DOI: 10.1136/ard.32.4.337

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  13 in total

1.  SPECIFIC NUCLEAR REACTION PATTERN OF ANTIBODY TO DNA IN LUPUS ERYTHEMATOSUS SERA.

Authors:  S P CASALS; G J FRIOU; P O TEAGUE
Journal:  J Lab Clin Med       Date:  1963-10

2.  A DNA-reacting factor in serum of a patient with lupus erythematosus diffusus.

Authors:  R CEPPELLINI; E POLLI; F CELADA
Journal:  Proc Soc Exp Biol Med       Date:  1957-12

3.  The relation of immunoglobulin class, pattern of anti-nuclear antibody, and complement-fixing antibodies to DNA in sera from patients with systemic lupus erythematosus.

Authors:  N F Rothfield; B D Stollar
Journal:  J Clin Invest       Date:  1967-11       Impact factor: 14.808

4.  Immunoglobulin class and pattern of nuclear fluorescence in systemic lupus erythematosus.

Authors:  E N Gonzalez; N F Rothfield
Journal:  N Engl J Med       Date:  1966-06-16       Impact factor: 91.245

5.  Serum antinuclear antibodies in rheumatoid arthritis.

Authors:  G D Hughes; N F Rothfield
Journal:  Conn Med       Date:  1970-03

6.  Deoxyribonucleic acid antibody: a method to detect its primary interaction with deoxyribonucleic acid.

Authors:  R T Wold; F E Young; E M Tan; R S Farr
Journal:  Science       Date:  1968-08-23       Impact factor: 47.728

7.  Serum anti-gamma-globulin and antinuclear factors in the aged.

Authors:  R J Cammarata; G P Rodnan; R H Fennell
Journal:  JAMA       Date:  1967-02-13       Impact factor: 56.272

8.  Studies on DNA antibodies using DNA labelled with actinomycin-D (3H) or dimethyl (3H) sulphate.

Authors:  R I Carr; D Koffler; V Agnello; H G Kunkel
Journal:  Clin Exp Immunol       Date:  1969-05       Impact factor: 4.330

9.  Anti-DNA activity in systemic lupus erythematosus. A diagnostic and therapeutic guide.

Authors:  G R Hughes; S A Cohen; C L Christian
Journal:  Ann Rheum Dis       Date:  1971-05       Impact factor: 19.103

10.  Serum antinuclear antibodies in progressive systemic sclerosis (scleroderma).

Authors:  N F Rothfield; G P Rodnan
Journal:  Arthritis Rheum       Date:  1968-10
View more
  5 in total

1.  Relation of titred peripheral pattern ANA to anti-DNA and disease activity in systemic lupus erythematosus.

Authors:  R J Weitzman; S E Walker
Journal:  Ann Rheum Dis       Date:  1977-02       Impact factor: 19.103

2.  A double antibody solid phase assay for DNA autoantibodies for clinical use.

Authors:  A Lange; I M Roitt; D Doniach
Journal:  Clin Exp Immunol       Date:  1976-08       Impact factor: 4.330

3.  Prognostic significance of DNA-binding capacity patterns in patients with lupus nephritis.

Authors:  M K Adler; A Baumgarten; B Hecht; N J Siegel
Journal:  Ann Rheum Dis       Date:  1975-10       Impact factor: 19.103

4.  Clinical significance of serum properdin levels and properdin deposition in the dermal-epidermal junction in systemic lupus erythematosus.

Authors:  M A Schrager; N F Rothfield
Journal:  J Clin Invest       Date:  1976-01       Impact factor: 14.808

5.  Prevention of glomerulonephritis and prolonged survival in New Zealand Black/New Zealand White F1 hybrid mice fed an essential fatty acid-deficient diet.

Authors:  E R Hurd; J M Johnston; J R Okita; P C MacDonald; M Ziff; J W Gilliam
Journal:  J Clin Invest       Date:  1981-02       Impact factor: 14.808

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.